---
title: "Eyebright Medical released its 2024 annual performance, with a net profit attributable to the parent company of 388 million yuan, a year-on-year increase of 27.77%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236991369.md"
description: "According to the Zhitong Finance APP, Eyebright Medical released its 2024 annual report, stating that the company's operating revenue for 2024 is CNY 1.41 billion, a year-on-year increase of 48.24%; the net profit attributable to shareholders of the listed company is CNY 388 million, a year-on-year increase of 27.77%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses is CNY 390 million, a year-on-year increase of 35.08%; the basic earnings per share is CNY 2.05"
datetime: "2025-04-22T13:43:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236991369.md)
  - [en](https://longbridge.com/en/news/236991369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236991369.md)
generator: "portal-rs"
---

# Eyebright Medical released its 2024 annual performance, with a net profit attributable to the parent company of 388 million yuan, a year-on-year increase of 27.77%

According to the Zhitong Finance APP, Eyebright Medical (688050.SH) released its annual report for 2024, reporting an operating income of 1.41 billion yuan for the year 2024, a year-on-year increase of 48.24%; a net profit attributable to shareholders of the listed company of 388 million yuan, a year-on-year increase of 27.77%; a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 390 million yuan, a year-on-year increase of 35.08%; and basic earnings per share of 2.05 yuan/share

### Related Stocks

- [688050.CN](https://longbridge.com/en/quote/688050.CN.md)

## Related News & Research

- [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [WindGroove Introduces AirFi One, a Ceiling-Based Home Entertainment System Combining Hi-Fi Sound, Light, and Airflow](https://longbridge.com/en/news/298221464.md)
- [Neuro Event Labs wins CMS NTAP coverage for Nelli seizure monitoring system, up to USD 975 per case](https://longbridge.com/en/news/298310708.md)
- [Trump's latest threat - to stop trading with some countries unless there's a rate cut - risks shock to U.S. economy](https://longbridge.com/en/news/298067979.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**